Valuation : Old API Wind-down Ltd.

Market Cap 87.35K 75.26K 71.26K 64.59K 121K 8.35M 122K 846K 325K 4.25M 328K 321K 13.42M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 212M 200M 182M 341M 23.48B 343M 2.38B 916M 11.94B 923M 903M 37.74B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.65%-2.93%+47.52%+87.34% 994B
-0.29%-3.51%+48.78%+63.27% 640B
+0.83%+0.26%+16.76%+72.52% 454B
-0.38%-3.59%+28.24%+35.57% 337B
-0.09%-13.54%+10.08%+26.87% 261B
-0.43%-2.48%-2.07%+11.48% 246B
-1.34%-13.70%+33.47%+44.18% 204B
-3.44%-7.51%-20.08%-59.58% 190B
-0.75%-4.82%+21.94%+86.55% 178B
Average -0.66%-5.18%+20.52%+40.91% 350.48B
Weighted average by Cap. -0.51%-4.42%+29.87%+55.71%

Financials

2016 2017
Net sales 54.27M 46.76M 44.27M 40.13M 75.29M 5.18B 75.67M 526M 202M 2.64B 204M 199M 8.34B 106M 91.28M 86.43M 78.34M 147M 10.12B 148M 1.03B 395M 5.15B 398M 389M 16.27B
Net income -103M -88.73M -84.01M -76.15M -143M -9.84B -144M -998M -384M -5.01B -387M -378M -15.82B -125M -108M -102M -92.58M -174M -11.96B -175M -1.21B -467M -6.09B -470M -460M -19.23B
Net Debt 209M 181M 171M 155M 291M 20.01B 292M 2.03B 781M 10.18B 787M 770M 32.18B 246M 212M 200M 182M 341M 23.47B 343M 2.38B 915M 11.94B 923M 902M 37.73B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!